Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 767689, 14 pages
http://dx.doi.org/10.1155/2013/767689
Research Article

Galangin Abrogates Ovalbumin-Induced Airway Inflammation via Negative Regulation of NF- B

1Department of Respiratory Medicine, The First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China
2Department of Respiratory Medicine, The Second Affiliated Hospital, Nanjing Medical University, 121 Jiangjiayuan Road, Nanjing 210011, China
3Department of Pathology, The First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China

Received 31 January 2013; Revised 14 April 2013; Accepted 25 April 2013

Academic Editor: Shuang-En Chuang

Copyright © 2013 Wang-Jian Zha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Anandan, U. Nurmatov, O. C. P. van Schayck, and A. Sheikh, “Is the prevalence of asthma declining? Systematic review of epidemiological studies,” Allergy, vol. 65, no. 2, pp. 152–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. la Van, D. M. Lynn, and R. Langer, “Moving smaller in drug discovery and delivery,” Nature Reviews Drug Discovery, vol. 1, no. 1, pp. 77–84, 2002. View at Google Scholar · View at Scopus
  3. D. T. Umetsu and R. H. DeKruyff, “The regulation of allergy and asthma,” Immunological Reviews, vol. 212, pp. 238–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Hogan, H. F. Rosenberg, R. Moqbel et al., “Eosinophils: biological properties and role in health and disease,” Clinical and Experimental Allergy, vol. 38, no. 5, pp. 709–750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. K. Patel, R. L. Clifford, K. Deacon, and A. J. Knox, “Ciclesonide inhibits TNFalpha- and IL-1beta-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells,” American Journal of Physiology, Lung Cellular and Molecular Physiology, vol. 302, no. 8, pp. L785–L792, 2012. View at Google Scholar
  6. P. Seidel, K. Hostettler, J. Hughes, M. Tamm, and M. Roth, “Dimethylfumarate inhibits CXCL10 via heme-oxygenase-1 in airway smooth muscle,” European Respiratory Journal, vol. 41, no. 1, pp. 195–202, 2013. View at Google Scholar
  7. C. W. Lee, C. C. Lin, S. F. Luo et al., “Tumor necrosis factor-α enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells,” Molecular Pharmacology, vol. 73, no. 5, pp. 1454–1464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Adcock, G. Caramori, and K. F. Chung, “New targets for drug development in asthma,” The Lancet, vol. 372, no. 9643, pp. 1073–1087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Hart, V. L. Krishnan, I. M. Adcock, P. J. Barnes, and K. F. Chung, “Activation and localization of transcription factor, nuclear factor-κB, in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 5, pp. 1585–1592, 1998. View at Google Scholar · View at Scopus
  10. I. W. Choi, D. K. Kim, H. M. Ko, and H. K. Lee, “Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-κB inhibits established asthmatic reaction in mice,” International Immunopharmacology, vol. 4, no. 14, pp. 1817–1828, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Morello, V. Vellecco, A. Alfieri, N. Mascolo, and C. Cicala, “Vasorelaxant effect of the flavonoid galangin on isolated rat thoracic aorta,” Life Sciences, vol. 78, no. 8, pp. 825–830, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Dambros, R. de Jongh, G. A. van Koeveringe, A. Bast, and P. E. V. van Kerrebroeck, “Galangin protects pig detrusor nerves from repetitive field stimulation and anoxia/glucopenia injury,” Urology, vol. 66, no. 6, pp. 1327–1331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Jeong-Eun, J. In-Tae, C. Junyoung et al., “The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-kappaB in collagen-induced arthritis and bone marrow-derived macrophages,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 57–66, 2013. View at Google Scholar
  14. E. Szliszka, Z. P. Czuba, J. Bronikowska et al., “Ethanolic extract of propolis augments TRAIL-induced apoptotic death in prostate cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 535172, 11 pages, 2011. View at Publisher · View at Google Scholar
  15. Q. Du, Z. Chen, L. F. Zhou, Q. Zhang, M. Huang, and K. S. Yin, “Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma,” Canadian Journal of Physiology and Pharmacology, vol. 86, no. 7, pp. 449–457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Bao, S. Guan, C. Cheng et al., “A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-κb pathway,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 8, pp. 657–665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Joubert, S. Lajoie-Kadoch, V. Wellemans et al., “Expression and regulation of CCL15 by human airway smooth muscle cells,” Clinical and Experimental Allergy, vol. 42, no. 1, pp. 85–94, 2012. View at Google Scholar
  18. P. Seidel, I. Merfort, J. M. Hughes, B. G. G. Oliver, M. Tamm, and M. Roth, “Dimethylfumarate inhibits NF-κB function at multiple levels to limit airway smooth muscle cell cytokine secretion,” American Journal of Physiology, Lung Cellular and Molecular Physiology, vol. 297, no. 2, pp. L326–L339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Google Scholar · View at Scopus
  20. R. Gagliardo, P. Chanez, M. Mathieu et al., “Persistent activation of nuclear factor-κB signaling pathway in severe uncontrolled asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 10, pp. 1190–1198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Yamamoto and R. B. Gaynor, “Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer,” Journal of Clinical Investigation, vol. 107, no. 2, pp. 135–142, 2001. View at Google Scholar · View at Scopus
  22. O. Pinkenburg, J. Platz, C. Beisswenger, C. Vogelmeier, and R. Bals, “Inhibition of NF-κB mediated inflammation by siRNA expressed by recombinant adeno-associated virus,” Journal of Virological Methods, vol. 120, no. 1, pp. 119–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Desmet, P. Gosset, B. Pajak et al., “Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma,” Journal of Immunology, vol. 173, no. 9, pp. 5766–5775, 2004. View at Google Scholar · View at Scopus
  24. M. A. Birrell, E. Hardaker, S. Wong et al., “Iκ-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 8, pp. 962–971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Elliott, C. S. Pien, T. A. McCormack, I. D. Chapman, and J. Adams, “Proteasome inhibition: a novel mechanism to combat asthma,” Journal of Allergy and Clinical Immunology, vol. 104, no. 2, pp. 294–300, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Damera, O. Tliba, and R. A. Panettieri Jr., “Airway smooth muscle as an immunomodulatory cell,” Pulmonary Pharmacology and Therapeutics, vol. 22, no. 5, pp. 353–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Das, C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray, “A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation,” Nature Immunology, vol. 2, no. 1, pp. 45–50, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. M. R. Edwards, N. W. Bartlett, D. Clarke et al., “Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease,” Pharmacology and Therapeutics, vol. 121, no. 1, pp. 1–13, 2009. View at Google Scholar
  29. W. W. Busse and R. F. Lemanske Jr., “Asthma,” The New England Journal of Medicine, vol. 344, no. 5, pp. 350–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Yamamoto, Y. Tochino, K. Chibana et al., “Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation,” Clinical and Experimental Allergy, vol. 42, no. 5, pp. 760–768, 2012. View at Google Scholar
  31. M. S. Harkins, K. L. Fiato, and G. K. Iwamoto, “Exhaled nitric oxide predicts asthma exacerbation,” Journal of Asthma, vol. 41, no. 4, pp. 471–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Brindicci, K. Ito, P. J. Barnes, and S. A. Kharitonov, “Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers,” Chest, vol. 132, no. 2, pp. 581–588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Chibana, J. B. Trudeau, A. T. Mustovich et al., “IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells (Clinical and Experimental Allergy (2008) (936-946)),” Clinical and Experimental Allergy, vol. 38, no. 8, p. 1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Prado, E. A. Leick-Maldonado, L. Yano et al., “Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling,” American Journal of Respiratory Cell and Molecular Biology, vol. 35, no. 4, pp. 457–465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. C. Li, C. H. Yeh, M. L. Yang, and Y. H. Kuan, “Luteolin suppresses inflammatory mediator expression by blocking the Akt/NFkappaB pathway in acute lung injury induced by lipopolysaccharide in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 383608, 8 pages, 2012. View at Publisher · View at Google Scholar
  36. S. Montefort, C. Gratziou, D. Goulding et al., “Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways,” Journal of Clinical Investigation, vol. 93, no. 4, pp. 1411–1421, 1994. View at Google Scholar · View at Scopus
  37. D. Quarcoo, S. Weixler, D. Groneberg et al., “Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, pp. 288–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. D. Leuppi, S. H. Downs, S. R. Downie, G. B. Marks, and C. M. Salome, “Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms,” Thorax, vol. 57, no. 6, pp. 518–523, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Cohn, J. S. Tepper, and K. Bottomly, “Cutting edge: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells,” Journal of Immunology, vol. 161, no. 8, pp. 3813–3816, 1998. View at Google Scholar · View at Scopus
  40. B. L. Bradley, M. Azzawi, M. Jacobson et al., “Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness,” Journal of Allergy and Clinical Immunology, vol. 88, no. 4, pp. 661–674, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. J. J. Lee, D. Dimina, M. P. Macias et al., “Defining a link with asthma in mice congenitally deficient in eosinophils,” Science, vol. 305, no. 5691, pp. 1773–1776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Du, T. J. McMahon, Z. S. Zhang, J. A. Stiber, G. Meissner, and J. P. Eu, “Excitation-contraction coupling in airway smooth muscle,” Journal of Biological Chemistry, vol. 281, no. 40, pp. 30143–30151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Liu, J. Zuo, E. Pertens, P. B. Helli, and L. J. Janssen, “Regulation of Rho/ROCK signaling in airway smooth muscle by membrane potential and [Ca2+]i,” American Journal of Physiology, Lung Cellular and Molecular Physiology, vol. 289, no. 4, pp. L574–L582, 2005. View at Publisher · View at Google Scholar · View at Scopus